Huge demand for weight loss drugs Ozempic and Wegovy continue to drive an incredible performance for
(c) 2024 City A.M., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
928.8 DKK | -0.92% | +2.82% | +33.05% |
05-25 | Wegovy users have less kidney-related health problems, analysis of Novo study finds | RE |
05-24 | Health Care Down on Rotation Out of Sector - Health Care Roundup | DJ |
Huge demand for weight loss drugs Ozempic and Wegovy continue to drive an incredible performance for
(c) 2024 City A.M., source
1st Jan change | Capi. | |
---|---|---|
+33.05% | 599B | |
+38.51% | 727B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B | |
+0.31% | 164B |